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Background: The Lablite project captured information on access to antiretroviral therapy (ART) at larger health
facilities (‘hubs’) and lower-level health facilities (‘spokes’) in Phalombe district, Malawi and in Kalungu district,
Uganda.
Methods: We conducted a cross-sectional survey among patients who had transferred to a spoke after treat-
ment initiation (Malawi, n=54; Uganda, n=33), patients who initiated treatment at a spoke (Malawi, n=50;
Uganda, n=44) and patients receiving treatment at a hub (Malawi, n=44; Uganda, n=46).
Results: In Malawi, 47% of patients mapped to the two lowest wealth quintiles (Q1–Q2); patients at spokes
were poorer than at a hub (57% vs 23% in Q1–Q2; p<0.001). In Uganda, 7% of patients mapped to Q1–Q2;
patients at the rural spoke were poorer than at the two peri-urban facilities (15% vs 4% in Q1–Q2; p<0.001).
The median travel time one way to a current ART facility was 60 min (IQR 30–120) in Malawi and 30 min (IQR
20–60) in Uganda. Patients who had transferred to the spokes reported a median reduction in travel time of
90 min in Malawi and 30 min in Uganda, with reductions in distance and food costs.
Conclusions: Decentralizing ART improves access to treatment. Community-level access to treatment should
be considered to further minimize costs and time.
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Background
Malawi and Uganda, like many sub-Saharan African countries,
have high burdens of HIV, with an estimated prevalence among
15–49 year olds of 11% and 7%, respectively.1,2 Decentralization
of antiretroviral therapy (ART) services to all health facilities to
ensure universal access is believed to be essential to realize
the United Nations sustainable development goal of ending the
AIDS epidemic by 2030.3 ART scale-up to public-sector facilities
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commenced in 2004 in Malawi and in 2003 in Uganda.4,5 It is
noteworthy that the roll-out of the Option B+ strategy (provi-
sion of lifelong ART for all pregnant and breastfeeding women)
signiﬁcantly accelerated decentralization of ART to peripheral
lower-level health centres in Malawi. Following Option B+ roll-
out, the number of facilities providing integrated ART in Malawi
doubled within a period of 6 months, from 303 in June 2011 to
more than 600 sites by the end of 2011.6 In Uganda, ART
scale-up happened more steadily, 1045 of 1309 (80%) Health
Centre IIIs (facilities serving a subcounty) were providing ART
for adults by June 2014.7 Despite signiﬁcant progress, ART
coverage (based on WHO 2013 guidelines criteria for eligibility
to start ART; CD4 <500 cells/μL) at the end of 2014 reached
only 67% in Malawi and 52% in Uganda.7,8 Furthermore if we
consider the WHO 2015 guidelines of universal treatment,9
then the ART coverage is even lower. Challenges remain at
each step of the HIV treatment cascade, from identifying and
testing HIV-positive individuals to retaining those who have
started treatment in care.10–12
The entry point of ART provision in sub-Saharan Africa was ini-
tially at tertiary- and large secondary-level health facilities, many
of which were located in urban areas; therefore, individuals living
in rural areas and poorer individuals were less likely to access HIV
testing and treatment services due to transport costs, distance to
facilities and other related socio-economic constraints.13–15 One
of the strategies that has driven ART decentralization to primary
care facilities is task-shifting, and this has been shown to reduce
patient attrition without compromising clinical outcomes.16–18
Studies on decentralization of ART to primary care facilities show
better clinical outcomes driven by good adherence, retention in
care and reduced loss to follow-up.19–21 However, there is limited
information on the challenges for patients, including time and
monetary costs, associated with accessing ART under different
health service delivery models.22
The Lablite project worked with the Ministries of Health in
Uganda, Malawi and Zimbabwe to investigate and support strat-
egies to roll out HIV treatment safely and cost-effectively to pri-
mary care facilities in rural settings.23 Project facilities were
selected by Ministries of Health, and training of health workers,
facility accreditation and ART provision were in accordance with
national guidelines. As part of the project, we conducted cross-
sectional surveys of patients attending a regular (non-research)
larger district-level facility (‘hub’) and two linked primary care
facilities (‘spokes’) in Malawi and Uganda. Information was col-
lected on patients’ characteristics and access to ART. The aims of
this study were to describe and compare the characteristics of
patients accessing ART at hubs and spokes, to quantify the costs
and challenges to patients of accessing ART and to describe any
patient-reported differences in time, distance and cost to care
following a transfer from hub to spoke.
Methods
Study setting
In Malawi, the project was implemented in Phalombe district in
the southeastern region of the country. All the spoke facilities were
rural, although the hub was located in the district town centre.
The hub, Holy Family Mission Hospital, a secondary referral hospital
run by the Christian Hospital Association of Malawi (CHAM), has
provided ART since 2008 and serves as the district referral hospital
through a service agreement with the Phalombe District Health
Ofﬁce, which supervises all health services in the district (including
hub and spoke sites). Within Phalombe district, during the Lablite
project period, there were 14 spoke sites providing decentralized
ART services, 5 of which had been providing ART services already
and 9 of which started decentralization during the project.
Decentralization of ART provision from hub to spoke sites was con-
ducted as per Malawi Ministry of Health guidelines and has been
previously described.24,25 The two spoke study sites selected for
this survey, Suksanje (45 km from the hub by dirt road) and Mpasa
(7 km from the hub by dirt road) Health Centres (HCs), are primary
health facilities that began decentralized provision of ART with the
roll-out of Option B+ in the last quarter of 2011 and ART to all eli-
gible patients since the second quarter of 2012. Prior to decentral-
ization, HIV testing and counselling services were available but
patients were referred for ART to either the hub site or to other lar-
ger spoke sites. ART services at the hub site are provided in a dedi-
cated HIV clinic by specialized clinicians and nurses, and with the
support of ART clerks and counsellors, and are generally well
staffed with dedicated stafﬁng compared with spoke sites. The
hub site, as a referral hospital, also provides inpatient surgical,
medical, paediatric, and labour and delivery services in addition to
multiple specialized outpatient clinics (including general out-
patient, antenatal and maternity care). In spoke sites, ART services
are provided by District Health Ofﬁce staff working at the site.
Typically spoke sites may have one medical assistant/clinical ofﬁ-
cer and one or two nurses providing general outpatient, antenatal
and maternity care. Health surveillance assistants, a formal com-
munity health worker cadre, provide ART clerk and counsellor sup-
port in spoke sites in addition to their other duties in health
promotion and prevention. In Uganda, the study was implemen-
ted in Kalungu district, in the central region of the country.
Bukulula HC IV (hub) supervises six HC IIIs (spokes); the two
spokes, Lukaya HC III (4 km to hub) and Kiragga HC III (26 km to
hub), were chosen in collaboration with the Ministry of Health and
the District Health Ofﬁce as part of planned decentralization of
ART to lower-level facilities. The hub and one of the spokes
(Lukaya HC III) were peri-urban, while Kiragga HC III was rural. In
Uganda, a HC III is headed by a clinical ofﬁcer, serves a subcounty
and provides inpatient care and outpatient, antenatal, immuniza-
tion and outreach services and environmental health; a HC IV is
headed by a medical ofﬁcer, serves a subdistrict and provides sur-
gery, supervision of the lower-level HCs, data collection and health
service planning, in addition to the services provided at the HC IIIs.
The hub has provided ART since 2005. The two spokes started ART
provision as outreach sites in the third quarter of 2012; Option B+
provision at the facilities began in the fourth quarter of 2012 and
general ART onsite commenced in the ﬁrst quarter of 2013. At the
spokes, ART services are provided by a team led by a clinical ofﬁcer
and one or two nurses providing general outpatient, antenatal
and maternity care; two to three community liaison volunteers/
expert patients offer counselling services, provide health talks and
participate in home visits. At the hub, the team is more advanced
in HIV treatment and care, and is led by a medical ofﬁcer sup-
ported by a larger team consisting of a clinical ofﬁcer, two to three
International Health
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nurses and four to ﬁve community liaison volunteers/expert
patients with similar roles as in the spokes.
At the end of 2013 there were 6348 patients registered on
ART at the hub in Malawi, 1312 at Sukasanje HC and 648 at
Mpasa HC. At the end of 2014 there were 998 patients regis-
tered on ART at the hub in Uganda, 68 at Kiragga HC and 182 at
Lukaya HC.
Study design
We conducted a cross-sectional survey among three groups of
ART patients at the health facilities: patients who were on ART at
the hub, patients who had initiated ART at a spoke and patients
who had transferred to a spoke on ART.We collected sociodemo-
graphic information and information on access to ART at the cur-
rent facility (time, cost, mode of transport) and at any previous
facility. At the spokes, we purposively sampled approximately
50% of patients newly initiating ART and 50% of patients trans-
ferring into the facility having started treatment elsewhere (in
Uganda, patients who started ART at the spokes during ART out-
reach provision and had not previously been treated elsewhere
were not included as transfers). Patients newly initiating ART
were approached if they had started treatment within the last 12
months (although when we looked at matched clinic data this
requirement was not always met). Interviewers visited the facil-
ities on ART clinic days and approached patients identiﬁed as eli-
gible from patient registers and patient clinic cards until the
quota was reached. We aimed to collect data on 50 patients at
each facility. Sample sizes were pragmatic to allow us sufﬁcient
numbers to describe key outcomes, including travel time and dis-
tance to facility, while limited by researcher time and patient
availability. Recruitment at the spokes proved difﬁcult in Uganda
because facilities were small. The interviews were conducted
between January 2013 and January 2014 in Malawi and between
February and October 2014 in Uganda.
Statistical analysis
The survey included most (but not all) questions used to derive
the asset index in the Demographic Health Survey (DHS) data. In
order to calculate a national asset index score for each study par-
ticipant, we had to map participants in the corresponding DHS.1,26
The same approach was followed for Malawi and Uganda. In
brief, we identiﬁed the overlapping questions between our survey
and the DHS (collapsing response categories where necessary).
We applied principal component analysis within the DHS data to
estimate a national asset index score and corresponding wealth
quintile cut-offs based on the variables common to the DHS and
our survey. Correlations between the asset scores generated from
the common set of variables and the asset scores for the full set
of variables in the DHS data were very high (Malawi, r=0.93;
Uganda, r=0.95). We applied the factor weights extracted from
the DHS data set to our corresponding data set to assign each
survey respondent a national asset index and then assigned a
wealth quintile based on the cut-offs in the DHS data.27,28
Most analyses were descriptive.Within each country we tested
for differences in patient characteristics and variables describing
access to care between facilities, between hubs and spokes, and,
at spokes, between patients newly initiating ART and patients
who transferred into the facility on ART. Access to care pre- and
post-transfer was compared among patients who transferred in
at the spokes. Proportions were compared using χ2 tests. The
Wilcoxon rank sum test or Kruskal–Wallis test (>2 groups) was
used to compare distributions of continuous variables between
groups. The Wilcoxon signed-rank test was used to compare con-
tinuous variables pre- and post-transfer in the same individuals.
All data were analysed using Stata 12.0 (StataCorp, College
Station, TX, USA).
Results
In Malawi, 44 patients were interviewed at the hub and 104
patients were interviewed at the spokes; 54/104 (52%) patients
at the spokes had started ART elsewhere and transferred in for
care (20% of transfers had received treatment at the hub prior to
transfer, 67% had transferred from other large primary care facil-
ities in the district with longer-established ART provision and 13%
had transferred from other facilities, including some out of the
district). In Uganda, 46 patients were interviewed at the hub and
77 patients were interviewed at the spokes; 33/77 (45%) patients
at the spokes had transferred into care (36% of transfers had
received treatment at the hub prior to transfer and the remainder
had transferred from a variety of facilities; see Table 1).
Characteristics of patients
The majority of patients were female (74% in Malawi, 72% in
Uganda). The median age at interview was 36 y (IQR 30–46) in
Malawi and 35 y (IQR 28–44) in Uganda. Education levels were
low (82% in Malawi, 67% in Uganda had not completed primary
Table 1. Number of participants interviewed at the hub and spokes in Malawi and Uganda
Malawi (n=148) Uganda (n=123)
Holy Family
Hospital (hub)
Sukasanje
HC (spoke)
Mpasa HC
(spoke)
Bukulua HC
(hub)
Kiragga HC
(spoke)
Lukaya HC
(spoke)
New ART initiations 24 26 22 22
Transfers in 29 25 18 15
Total patients 44 53 51 46 40 37
G. Abongomera et al.
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education) and the principal occupation was farming (68% in
Malawi, 62% in Uganda).
Characteristics of the patients are shown in Table 2 by facility
and in Table 3 for patients at the spokes split by those newly initi-
ating ART and those transferring into the facility on ART. In
Uganda, patients interviewed at spokes tended to be younger
than patients at the hub (p=0.002); there was no difference by
facility in Malawi (p=0.21) (Table 2). Proportionally more females
were interviewed at the spokes than at the hubs (79% vs 61%
[p=0.03] in Malawi; 81% vs 59% [p=0.009] in Uganda), probably
related to Option B+ provision, which rolled out at the spokes
ahead of general ART. Where information on the reason for ART
initiation was available, higher proportions of women initiated for
Option B+ at the spokes than the hubs (45% vs 24% [p=0.06] in
Malawi, 66% vs 10% [p<0.001] in Uganda). Education levels were
similar across facilities in Malawi (p=0.57). In Uganda, education
levels differed between facilities (p=0.01); patients at the rural
spoke (Kiragga HC) had lower levels of education than patients at
the other two peri-urban facilities.
In Malawi, the asset index differed by facility. Patients tended
to be poorer at the spokes than at the hub (p<0.001) (Figure 1a);
25% of patients at the spokes were in the lowest national wealth
quintile and 57% fell into one of the two lowest quintiles. This dif-
ference in asset index between hub and spokes persisted if
Option B+ women and women with an unknown reason for ART
initiation were excluded (p<0.001). In Uganda, the asset index
also differed by facility (p<0.001) (Figure 1b). Patients at the rural
spoke (Kiragga HC) were on average poorer than patients at the
other peri-urban facilities; 15% of patients at the rural spoke
were in one of the two lowest quintiles, compared with only 4%
at the other peri-urban facilities. Excluding Option B+ women and
women with an unknown reason for ART initiation, evidence of
patients at Kiragga HC being poorer remained (p=0.002).
Characteristics of the patients at the spokes who started ART
at the facility were no different from those who transferred into
the spokes for follow-up on ART, with the exception of time on
ART; transfers in were more likely to have been on ART longer at
the time of interview (Table 2). There was no evidence that trans-
fers were wealthier than patients newly initiating ART (p=0.90,
Malawi; p=0.22, Uganda).
Access to ART services
The distance patients travelled and time taken to travel to their
current ART facility are summarized in Table 4. In Malawi, the
median distance travelled was 6 km (IQR 2–11) and the time taken
was 1 h (IQR 30–120 min); the majority of patients walked (66%).
There was no difference between facilities in either distance to the
facility (p=0.14) or time to travel to the facility (p=0.11). A higher
proportion walked to the spokes (74%) than to the hub (48%;
p=0.002). In Uganda, the median distance travelled was 4 km (IQR
1.5–8) and time taken was 30 min (IQR 20–60); 40% of patients
walked, 13% travelled by bike and the remaining 47% used motor-
ized transport (mostly motorbike taxi). Patients travelled further to
the hub on average than to the spokes (p<0.001) and took longer
to travel there (p<0.001). The majority used motorized transport to
travel to the hub (61%), with only 22% walking to the hub. More
walked to the spokes (51%; p=0.007).
In Malawi, only ﬁve patients paid for transport (all at the
hub). The cost of food per visit was higher at the spokes than at
the hub (p<0.001) (Table 4); 21% of hub patients reported incur-
ring food costs, compared with 63% of patients attending
spokes. In Uganda, transport costs were incurred by 46% of
patients; the average transport costs were higher at the hub
than at the spokes (p<0.001). The expenditure on food per visit
was also higher at the hub than at the spokes (p<0.001); 89%
of patients reported incurring food costs at the hub compared
with 45% of patients at the spokes.
In Malawi, 67% of patients at the hub said there was a closer
ART facility to home and none at the spokes; corresponding num-
bers for Uganda were 35% and 16%, respectively. At the hubs,
most patients who gave a reason for not moving to a facility clo-
ser to home said they liked the facility they were at (23 in Malawi,
6 in Uganda). Five patients at the Ugandan hub were in the pro-
cess of transferring closer to home. Only three patients (all in
Malawi) reported that they did not want to receive ART close to
home for fear of people knowing they were on HIV treatment.
Seven of the 12 patients at the spokes in Uganda reported their
nearest clinic was a ‘Uganda Cares clinic’, which is less than a 5
min walk from Lukaya HC where they were being seen; 2 liked the
clinic they were at and 2 worked at the clinic they were at.
Patient-level beneﬁts of decentralizing ART
All 54 patients at the spokes in Malawi who had transferred in for
care while already on ART had moved to receive treatment closer
to home (62% patient request, 38% clinician referral). In Uganda,
58% had moved to be closer to home (52% patient request, 6%
clinician referral); other reasons for transferring included a
change in circumstances (15%), reducing travel or clinic costs
(12%), reducing clinic waiting time (9%) and other (6%).
In Malawi, patients who transferred to a spoke reported sig-
niﬁcant savings in time spent travelling to the clinic post-transfer
(median 90 min [IQR 40–145]; p<0.001) (Table 5 and Figure 2).
Corresponding reductions in distance to the health facility were
also reported (median 7.6 km [IQR 3–11]; p<0.001). The majority
of patients walked (70%) to their ART facility pre-transfer and to
their current facility (74%); although there were no patient-borne
costs of travel pre- or post-transfer, two patients were taken by
ambulance pre-transfer, and this was no longer necessary. In
Uganda, the median reductions in time (30 min [IQR 10–60]) and
distance (4 km [IQR 3.5–6]) were less than in Malawi, but there
were substantial changes in the mode of transport, with only 6%
of patients walking or using their own or a borrowed bike pre-
transfer compared with 58% post-transfer, leading to signiﬁcant
savings in transport costs. The median travel costs per round trip
in Uganda decreased by US$1.80 (Table 5). In both countries
there were reported reductions in the median cost of food per vis-
it among patients who transferred to the spoke, although reduc-
tions were less in Malawi than in Uganda (from US$0.25 to 0.23
in Malawi and by US$0.40 in Uganda) (Table 5).
Discussion
Barriers to ART access that affect different subgroups of people
disproportionately can exacerbate inequality in access and
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Table 2. Characteristics of participants at interview by current ART facility
Malawi Uganda
Hub (n=44) Sukasanje HC
(n=53)
Mpasa HC (n=51) Spokes combined
(n=104)
Hub vs
spokes,
p-value
Hub (n=46) Kiragga HC
(n=40)
Lukaya HC
(n=37)
Spokes
combined
(n=77)
Hub vs
spokes,
p-value)
Age, median
(IQR), y
38 (30–46) 38 (31–50) 35 (29–40) 36 (30–47) 0.91 40 (31–49) 33 (28–45) 33 (25–39) 33 (26–42) 0.002
Sex, n (%)
Male 17 (39) 12 (23) 10 (20) 22 (21) 0.03 19 (41) 10 (25) 5 (14) 15 (19) 0.009
Female 27 (61) 41 (77) 41 (80) 82 (79) 27 (59) 30 (75) 32 (87) 62 (81)
Reason for starting ART, n (%)
Male for own
health
17 (39) 12 (23) 10 (20) 22 (21) 0.04 19 (41) 10 (25) 5 (14) 15 (19) <0.001
Female for
own health
19 (43) 29 (55) 14 (27) 43 (41) 18 (39) 6 (15) 7 (19) 13 (17)
Female for
Option B+
6 (14) 12 (23) 23 (45) 35 (34) 2 (4) 14 (35) 11 (30) 25 (32)
Female, not
known
2 (5) 0 (0) 4 (8) 4 (4) 7 (15) 10 (25) 14 (38) 24 (31)
Time on ART, n (%)
<6 months 26 (81) 21 (41) 22 (49) 43 (45) 0.002 9 (29) 14 (67) 5 (22) 19 (43) 0.003
6–12 months 3 (9) 11 (22) 7 (16) 18 (19) 3 (10) 2 (10) 7 (30) 9 (20)
12–24 months 3 (9) 10 (20) 14 (31) 24 (25) 10 (33) 5 (24) 10 (44) 15 (34)
≥24 months 0 (0) 9 (18) 2 (4) 11 (11) 9 (29) 0 (0) 1 (4) 1 (2)
Highest education attained, n (%)
None/pre-
primary
7 (17) 13 (25) 10 (20) 23 (22) 0.66 8 (17) 12 (30) 6 (16) 18 (23) 0.75
Some primary 27 (64) 32 (60) 30 (59) 62 (60) 23 (50) 22 (55) 12 (32) 34 (44)
Completed
primary
4 (10) 3 (6) 4 (8) 7 (7) 8 (17) 1 (3) 5 (14) 6 (8)
Some
secondary
3 (7) 4 (8) 6 (12) 10 (10) 3 (7) 5 (13) 14 (38) 19 (25)
Completed
secondary
1 (2) 1 (2) 1 (2) 2 (2) 3 (7) 0 (0) 0 (0) 0 (0)
Higher 0 (0) 0 (0) 0 (0) 0 (0) 1 (2) 0 (0) 0 (0) 0 (0)
Main occupation, n (%)
Farmer 35 (80) 35 (66) 31 (61) 66 (63) 0.14 33 (72) 33 (83) 10 (27) 43 (56) 0.11
Employee 3 (7) 3 (6) 2 (4) 5 (5) 4 (9) 4 (10) 13 (35) 17 (22)
4 (9) 10 (19) 16 (31) 26 (25) 6 (13) 1 (3) 8 (22) 9 (12)
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Family
business/
self-
employed
Causal labour 2 (5) 5 (9) 2 (4) 7 (7) 3 (7) 1 (3) 2 (5) 3 (4)
Other 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1* (3) 4** (11) 5 (6)
Asset index
score, median
(IQR)
0.3 (−1.0–1.3) −1.1 (−1.7–0.1) −1.1 (−1.5 to −0.2) −1.1 (−1.6 to −0.2) <0.001 0.9 (0.3–1.8) 0.6 (−0.1–1.1) 1.9 (0.9–3.1) 0.9 (0.3–1.9) 0.99
Wealth quintile, n (%)
Lowest 4 (9) 14 (26) 12 (24) 26 (25) 0 (0) 1 (3) 0 (0) 1 (1)
2 6 (14) 18 (34) 15 (29) 33 (32) 1 (2) 5 (13) 2 (5) 7 (9)
3 11 (25) 7 (13) 15 (29) 22 (21) 14 (30) 10 (25) 5 (14) 15 (19)
4 16 (36) 11 (21) 7 (14) 18 (17) 17 (37) 20 (50) 8 (22) 28 (36)
Highest 7 (16) 3 (6) 2 (4) 5 (5) 14 (30) 4 (10) 22 (59) 26 (34)
Unless speciﬁed percentages are of non-missing values.
*Housewife; **one ﬁsherman, three housewives.
InternationalH
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Table 3. Characteristics of participants at interview at the spokes by status at ART registration at the facility
Malawi Uganda
New ART
initiation
(n=50)
Transfer in on ART
(n=54)
All patients
(n=104)
New ART
initiation vs
transfer in,
p-value
New ART
initiation
(n=44)
Transfer in on
ART (n=33)
All patients
(n=77)
New ART
initiation vs
transfer in,
p-value
Age, median (IQR), y 35 (28–48) 36 (31–45) 36 (30–47) 0.31 30 (25–41) 35 (29–42) 33 (26–42) 0.12
Sex, n (%)
Male 9 (18) 13 (24) 22 (21) 0.45 8 (18) 7 (21) 15 (19) 0.74
Female 41 (82) 41 (76) 82 (79) 36 (82) 26 (79) 62 (81)
Reason for starting ART, n (%)
Male for own health 9 (18) 13 (24) 22 (21) 0.60 8 (18) 7 (21) 15 (19) 0.98
Female for own health 22 (44) 21 (39) 43 (41) 8 (18) 5 (15) 13 (17)
Female for Option B+ 16 (32) 19 (35) 35 (34) 14 (32) 11 (33) 25 (32)
Female, not known 3 (6) 1 (2) 4 (4) 14 (32) 10 (30) 24 (31)
Time on ART, n (%)
<6 months 35 (76) 8 (16) 43 (45) <0.001 17 (59) 2 (13) 19 (43) <0.001
6–12 months 8 (17) 10 (20) 18 (19) 7 (24) 2 (13) 9 (20)
12–24 months 3 (7) 21 (42) 24 (25) 5 (17) 10 (67) 15 (34)
≥24 months 0 (0) 11 (22) 11 (11) 0 (0) 1 (7) 1 (2)
Highest education attained, n (%)
None/pre-primary 17 (34) 6 (11) 23 (22) 0.06 10 (23) 8 (24) 18 (23) 0.45
Some primary 24 (48) 38 (70) 62 (60) 18 (41) 16 (48) 34 (44)
Completed primary 4 (8) 3 (6) 7 (7) 3 (7) 3 (9) 6 (8)
Some secondary 4 (8) 6 (11) 10 (10) 13 (30) 6 (18) 19 (25)
Completed secondary 1 (2) 1 (2) 2 (2) 0 (0) 0 (0) 0 (0)
Main occupation, n (%)
Farmer 35 (70) 31 (57) 66 (63) 0.34 23 (52) 20 (61) 43 (56) 0.06
Employee 1 (2) 4 (7) 5 (5) 14 (32) 3 (9) 17 (22)
Family business/self-employed 12 (24) 14 (26) 26 (25) 4 (9) 5 (15) 9 (12)
Causal labour 2 (4) 5 (9) 7 (7) 0 (0) 3 (9) 3 (4)
Other 0 (0) 0 (0) 0 (0) 3* (7) 2** (6) 5 (6)
Asset index score, median (IQR) −1.1 (−1.7–0.1) −1.2 (−1.6 to −0.5) −1.1 (−1.6 to −0.2) 0.90 1.0 (0.5–2.4) 0.7 (0.1–1.5) 0.9 (0.3–1.9) 0.22
Wealth quintile, n (%)
Lowest 14 (28) 12 (22) 26 (25) 1 (2) 0 (0) 1 (1)
2 13 (26) 20 (37) 33 (32) 2 (5) 5 (15) 7 (9)
3 11 (22) 11 (20) 22 (21) 6 (14) 9 (27) 15 (19)
4 10 (20) 8 (15) 18 (17) 17 (39) 11 (33) 28 (36)
Highest 2 (4) 3 (6) 5 (5) 18 (41) 8 (24) 26 (34)
Unless speciﬁed, percentages are of non-missing values.
*Three housewives; **one ﬁsherman, one housewife.
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ultimately health outcomes. One of the most commonly cited
barriers to accessing ART services is the cost associated with tra-
vel to the health facility.13,15,29–31 Travel to the health facility pre-
sents both direct monetary and indirect opportunity costs (such
as time taken off from work). In this study we captured informa-
tion on access to ART before and after transferring into lower-
level health facilities in 87 patients in Malawi and Uganda; the
majority of these patients transferred as a result of decentraliza-
tion of ART services to facilities nearer to where they live.
In both countries, patients who had transferred to the pri-
mary care facilities (spokes) for follow-up after initiating ART
elsewhere reported signiﬁcant savings in time spent travelling to
their ART facility and reductions in the distance from home to
the facility post-transfer. In Uganda, a substantial proportion
was able to walk to care, having previously used paid transport,
resulting in savings in transport costs; a median saving per
round trip of US$1.80 is substantial when 33% of the population
lives on less than US$2 per day and 63% on less than US$3.32
Although in Malawi most patients walked to their health facility,
an earlier study in Malawi found that patients accessing care at
a tertiary referral hospital incurred signiﬁcantly higher travel-
related expenses than patients in decentralized care.13 In both
countries there were reductions in the cost of food per visit to
the health facility; although reductions were less in Malawi than
in Uganda, the population in Malawi is poorer, with 70% living
on less than US$2 per day.32 These direct beneﬁts to patients
may explain why some studies on decentralization of ART have
shown reduced loss to follow-up and better adherence and
retention in care in local vs centralized care.19–21
Despite the beneﬁts of decentralization, patients at the pri-
mary care facilities in Malawi were still travelling (one way) on
average for 1 h to access ART services, mostly on foot, similar to
ﬁndings for patients accessing ART in decentralized care in
Zomba district, Malawi.13 In Uganda, patients travelled for half
an hour. If one adds this to the time spent at the facility, a sub-
stantial amount of time is still required to access ART services
and most patients collect drugs at least every 3 months, often
more frequently, particularly if drug supplies are low. Although
children were not included in this study, children and some
adults need to be accompanied to the facility, increasing the
burden on the population. Pinto et al.13 reported additional bar-
riers to accessing care, including missing work and lost income,
which we did not measure. As patients will be on ART for life,
there is an urgent need to consider alternative ways to deliver
ART to stable patients, for example drug collection points within
the community or supplies of ART for longer periods of time.33
At the hubs, signiﬁcant proportions of patients reported not
accessing ART at their nearest ART facility. There seemed to be
reluctance to move to a new facility having started ART in sec-
ondary care, which we have found previously in northern
Uganda and others have also reported.34–36 In contrast to some
previous studies,37 stigma did not appear to be a major barrier
to treatment close to home. It may be that despite poverty,
some patients prefer accessing treatment at secondary facilities
(hubs), even if further from home, due to their perceived higher
quality of care. The extent to which the interplay between these
factors affects access is not yet fully understood.38
Anonymous HIV testing in DHS studies in the past has shown
that HIV is present disproportionately among individuals of higher
socio-economic status.39 It is not clear to what extent, because
in the past ART was initially only available to wealthier individuals;
this may now be changing with the availability of free treatment
and greater ART coverage. Patients included in this study in
Malawi represented the region’s socio-economic distribution.
Patients receiving care at the spokes were poorer than those at
the hub. This suggests that decentralization is beneﬁting poorer
individuals; an alternative, less likely explanation is that richer
patients are more able to stay at hubs, particularly if fee-paying,
which is the case for some in Malawi. Patients in Uganda
appeared better off on average than others in the region, with
the possible exception of the rural spoke. Notably, 82% of the
population in Uganda resides in rural areas, so decentralization is
probably also beneﬁting the poorer population here.40 The peri-
urban spoke is located closer to the hub, close to a major high-
way to Kampala and is a truck driver’s stopping point, providing
opportunities for income for inhabitants, and is therefore not typ-
ical of primary care facilities.
Prior to collecting the data, we hypothesized that patients
transferring into the spokes on ART might be wealthier than
patients newly initiating ART at the spokes, reasoning that some
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Figure 1. Proportion of patients interviewed by wealth quintile at the study facilities compared with population ﬁgures for the corresponding region.
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Table 4. Access to current ART facility
Malawi Uganda
Hub (n=44) Sukasanje HC
(n=53)
Mpasa HC
(n=51)
Spokes
combined
(n=104)
Hub (n=46) Kiragga HC
(n=40)
Lukaya HC
(n=37)
Spokes
combined
(n=77)
Distance, median (IQR), km 5 (2–17) 7 (4–10) 5 (1–8) 6 (2–9.5) 7 (4–17) 3 (1.5–7) 2.5 (1–5) 3 (1–5)
Time, median (IQR), min 60 (30–120) 80 (60–120) 60 (20–100) 60 (30–120) 60 (30–60) 30 (18–105) 20 (10–30) 30 (15–40)
Mode of transport, n (%)
On foot 21 (48%) 40 (75%) 36 (72%) 76 (74%) 10 (22%) 20 (50%) 19 (51%) 39 (51%)
Own/borrowed bicycle 18 (41%) 12 (23%) 14 (28%) 26 (25%) 8 (17%) 7 (18%) 0 (0%) 7 (9%)
Bicycle taxi 2 (5%) 1 (2%) 0 (0%) 1 (1%) 0 (0%) 0 (0%) 1 (3%) 1 (1%)
Motorbike/motorbike taxi 0 (0%) 0 (0%) 0 (0%) 0 (0%) 18 (39%) 12 (30%) 15 (41%) 27 (35%)
Bus/car taxi 3 (7%) 0 (0%) 0 (0%) 0 (0%) 10 (22%) 0 (0%) 2 (5%) 2 (3%)
Lift 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (3%) 0 (0%) 1 (1%)
Cost of transport per round trip ($US)*1
Median (IQR) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 1.40 (0–2.40) 0 (0–0.80) 0 (0–1.20) 0 (0–0.80)
Mean (SD) 0.09 (0.27) 0 (0) 0 (0) 0 (0) 1.97 (3.03) 0.42 (0.73) 0.61 (0.79) 0.51 (0.76)
Cost of food per visit ($US)*
Median (IQR) 0 (0–0) 0.25 (0–0.50) 0.11 (0–0.38) 0.20 (0–0.38) 0.80 (0.4–1.20) 0 (0–0.80) 0 (0–0.40) 0 (0–0.70)
Mean (SD) 0.13 (0.34) 0.30 (0.32) 0.19 (0.23) 0.25 (0.28) 0.78 (0.46) 0.32 (0.37) 0.30 (0.42) 0.31 (0.39)
Malawi missing time to facility for 1 individual at the hub; missing distance to facility for 1 individual at the hub; missing costs for food for 16 at the hub and 1 at Mpasa.
Uganda data were incomplete for distance (available for n=33, 27 and 34 in the three facilities) and cost of food (n=45,39 and 27 in the three facilities)
*Conversion rates: 400 MKW to US$1 (April 2013); 2500 UGX to US$1 (April 2014) (www.exchangerates.org.uk).
1Costs of transport were only incurred for bicycle taxi, motorbike/motorbike taxi or bus/car taxi; ﬁve individuals at the hub in Malawi incurred costs ($0.5 [n=2]; $1 [n=3]). All
individuals using these forms of transport incurred costs in Uganda.
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new ART patients may not have been able to access ART previ-
ously due to cost. We found no evidence for this in either
Malawi or Uganda. However, we conducted the surveys soon
after general ART provision started (8 months in Malawi, 11
months in Uganda); it is possible that it may take longer for
such patients to come forward (particularly if they had resisted
testing until local ART services became available). A Lablite
population survey in northern Uganda showed an increase at
the population level in HIV testing at primary health care facil-
ities after decentralization of ART.36
This study did not compare clinical or laboratory outcomes
between participants at spokes and hubs. Cross-sectional mea-
sures were not easily available, as viral loads were not measured
at any of these sites during the study period; in Malawi, CD4 mon-
itoring was not available for patients on ART and, in Uganda, CD4
monitoring was incomplete. It is likely that participants who
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Figure 2. Comparison between travel time to current ART facility and travel time to previous ART facility in patients who have transferred into pri-
mary care facilities for follow-up on ART. All points below the lines are patients who spend less time travelling after transfer.
Table 5. Beneﬁts in access for patients transferring into the spokes from other health facilities
Malawi (n=54) Uganda (n=33)
Pre-transfer Post-transfer Reductiona Pre-transfer Post-transfer Reductiona
Distance, median (IQR), km 13 (8–18) 6 (2–8.4) 7.6 (3–11)*** 7.5 (4.5–11) 2 (1–4) 4 (3.5–6)**
Time, median (IQR), min 150 (90–240) 60 (30–120) 90 (40–145)*** 55 (30–120) 30 (10–40) 30 (10–60)***
Mode of transport, n (%)
On foot 37 (70) 39 (74) 1 (3) 15 (45)
Own/borrowed bicycle 14 (26) 13 (25) 1 (3) 4 (12)
Bicycle taxi 0 (0) 1 (2) 2 (6) 0 (0)
Motorbike/motorbike taxi 0 (0) 0 (0) 19 (58) 13 (39)
Bus/car taxi 0 (0) 0 (0) 10 (30) 1 (3)
Lift 0 (0) 0 (0) 0 (0) 0 (0)
Workstation ambulance 2 (4) 0 (0) 0 (0) 0 (0)
Cost of transport per round trip (US$)*
Median (IQR) 0 (0–0) 0 (0–0) 0 (0–0) 2.80 (1.20–5.60) 0 (0–1.00) 1.80 (1.20–4.0)***
Mean (SD) 0 (0) 0 (0) 0 (0) 3.83 (3.35) 0.59 (0.81) 3.24 (3.41)
Cost of food per visit (US$)*
Median (IQR) 0.25 (0.15–0.50) 0.23 (0–0.50) 0 (0–0.15)** 0.80 (0.60–1.20) 0 (0–0.80) 0.40 (0.40–0.80)***
Mean (SD) 0.33 (0.24) 0.27 (0.31) 0.06 (0.23) 0.96 (0.58) 0.35 (0.43) 0.61 (0.59)
aChange pre-transfer to post-transfer.
*Conversion rates: 400 MKW to US$1 (April 2013); 2500 UGX to US$1 (April 2014) (www.exchangerates.org.uk).
**p<0.01; ***p<0.001 (signed-rank test).
Distance data were only available for 12 patients pre-transfer and 11 patients post-transfer in Uganda.
International Health
17
Downloaded from https://academic.oup.com/inthealth/article-abstract/10/1/8/4797302
by London School of Hygiene & Tropical Medicine user
on 21 February 2018
transferred into spokes on ART were stable on ART at the time of
transfer and patients with complications would have remained at
the hub. Other longitudinal studies have reported better out-
comes for patients at decentralized facilities.24
Other limitations of the study include the sampling frame,
which was not random, but purposeful and convenience-based,
and the limited number of facilities included per country. Because
ART provision at the spokes started with Option B+, women starting
ART for Option B+ were probably over-represented at the spokes,
although this may continue for some time to come. It is also pos-
sible that women and/or individuals with no education were more
willing to be interviewed.We relied on patient reports, which may
be inaccurate, particularly for questions relating to distance trav-
elled and time taken to travel to the facility. We only collected
information from patients at the facilities, so we had no informa-
tion on HIV-positive individuals not accessing ART; this limits our
ability to assess equitable coverage of ART by socio-economic fac-
tors. Furthermore, the demographic health surveys in both coun-
tries were conducted in 2011 and our survey was conducted in
2013–2014; there may have been improvements in the wealth
index over this period (particularly in Uganda, where Kalungu dis-
trict is close to Masaka and Kampala), which would have caused
us to underestimate the proportions of patients accessing ART
from the lower socio-economic strata. Descriptions of the beneﬁts
of transferring from hub to spoke are based on those who chose
to transfer and may therefore overestimate average beneﬁts
attributable to decentralization. In particular, we did not collect
data on patient satisfaction with ART services, which is an import-
ant driver of the choice of facility.
Conclusions
Decentralization of ART services closer to home was shown to be
beneﬁcial to patients who transferred to their local facility, with
reductions in distance to the facility, travel time and out-of-pocket
expenses. In Malawi, patients receiving care at the spokes were
poorer than those at the hub and, in Uganda, patients at the rural
spoke were poorer than those in the peri-urban facilities, suggest-
ing that decentralization is beneﬁting poorer individuals. Our ﬁnd-
ings show that Malawi’s national ART programme is reaching all
socio-economic strata. In Uganda, we found less evidence for
equal access to ART across all socio-economic strata, although we
had no population-level information on the socio-economic status
of HIV-infected individuals in the facility catchment areas. Models
of community-level access to ART and reductions in clinic visit fre-
quency (e.g., adoption of the WHO differentiated model of care)41
aimed at further minimizing distance and patient-related costs in
accessing ART should be studied.
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